Differently, Leung et al. [99] reported the chemical conjugation of organic–inorganic hybrid nanovesicles to anti-EGFR mAbs, which retain the ability to bind to EGFR and inhibit A431 epidermoid carcinoma cell proliferation. This evidence concerns the gene EGFR and squamous cell carcinoma.